Welcome to our dedicated page for Confluent SEC filings (Ticker: CFLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Confluent, Inc. (NASDAQ: CFLT) files reports and disclosures with the U.S. Securities and Exchange Commission (SEC) in connection with its listing on the Nasdaq Global Select Market and its status as a public company. These filings provide detailed information on its data streaming business, financial condition, and significant corporate events.
Among the key documents for CFLT are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Confluent’s operations as a data streaming platform provider, outline its revenue from subscriptions and services, and discuss risks and other disclosures. Investors often review these filings to understand how Confluent presents its business model, including offerings such as Confluent Cloud, Confluent Platform, WarpStream, Confluent Private Cloud, Confluent Intelligence, Streaming Agents, Real-Time Context Engine, and Tableflow.
Confluent also uses Form 8-K current reports to disclose material events. For example, a Form 8-K dated December 8, 2025 describes an Agreement and Plan of Merger with International Business Machines Corporation (IBM) and a wholly owned IBM subsidiary. That filing outlines the proposed merger structure, the cash consideration for shares, the treatment of equity awards, closing conditions, termination rights, and potential termination fees. Other 8-K filings referenced in the available data report the release of quarterly financial results.
On this SEC filings page, users can access Confluent’s historical and ongoing disclosures, including 10-K, 10-Q, and 8-K filings, as well as proxy materials related to the IBM transaction once filed. The platform also surfaces Form 4 insider transaction reports and other ownership-related filings when available, allowing investors to monitor changes in holdings by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight major risk factors, and clarify complex transaction terms. Real-time updates from the SEC’s EDGAR system help ensure that new CFLT filings, including those related to the pending IBM merger, are quickly available with plain-language explanations.
A holder of CFLT common stock has filed a Rule 144 notice to sell 60,000 shares through Morgan Stanley Smith Barney LLC on or around February 13, 2026 on the NASDAQ market. The filing lists an aggregate market value of 1831200.00 for this block and notes that 308,661,566 shares of this class were outstanding.
The 60,000 shares were acquired on September 16, 2014 via an in-kind distribution post‑IPO from the issuer, with no separate cash payment. The filing also details recent Rule 10b5‑1 plan sales by related trusts, including blocks of 15,000 shares for proceeds of about 450000.00 and 447600.00.
Confluent insider plans a sizable stock sale under Rule 144. A holder of Confluent common stock filed notice to sell 640,000 shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,532,800.00. These shares are part of the company’s common stock listed on NASDAQ, with 308,661,566 shares outstanding.
The shares to be sold were acquired as founder shares from the issuer on 09/01/2014. The filing also lists recent Rule 10b5-1 plan sales of Confluent common stock over the past three months by related parties, showing multiple transactions with individual gross proceeds ranging from about $664,590.00 to $10,000,990.00.
Confluent insider plans to sell common stock under Rule 144. A holder filed to sell 80,000 shares of Confluent common stock through Morgan Stanley Smith Barney, with an aggregate market value of $2,441,600.00. Confluent had 308,661,566 shares outstanding as of this notice.
The shares to be sold were acquired by exercising stock options on 02/13/2026, paid in cash on the same date. The notice also lists multiple recent Rule 10b5-1 plan sales of Confluent common stock over the prior three months by related holders, showing ongoing, pre-arranged selling activity.
CFLT received a Form 144 notice covering a proposed sale of restricted or control 120,000 shares of common stock, with an aggregate market value of 3662400.00. The shares are expected to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 02/13/2026. The filing shows 308,661,566 shares of this class outstanding.
The seller acquired these shares as Founders Shares from the issuer on 09/01/2014. The notice also summarizes recent Rule 10b5-1 planned sales in the past three months by related holders, including entities and individuals at the same address, with multiple transactions in December 2025. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
A holder associated with CFLT has filed a Rule 144 notice to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/13/2026 on NASDAQ, with an aggregate market value of $763,000. These shares were acquired on 02/03/2023 via a distribution from Index Ventures. The notice also reports prior Rule 10b5-1 sales on 12/08/2025, including 32,038 common shares for Michelangelo Volpi for gross proceeds of $953,883.39 and 17,962 common shares for the Volpi-Cupal Family Trust for gross proceeds of $534,791.61.
A shareholder of CFLT has filed a Form 144 notice to potentially sell 1,905 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of 58140.60 and an approximate sale date of 02/13/2026.
The shares were acquired on 09/26/2014 via an in-kind distribution post-IPO from the issuer. Over the past three months, 10b5-1 plan sales for The Vishria Revocable Trust and The Khakal Trust included 15,000-share transactions on 12/10/2025 and 12/08/2025 with gross proceeds of 450000.00 and 447600.00, plus 476-share sales on the same dates with proceeds of 14280.00 and 14203.84. The signing party represents they do not know any undisclosed material adverse information about the issuer.
Ryan Mac Ban has filed a notice relating to the planned sale of 1,655 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. The aggregate market value of these shares is listed as $50,510.60, with 308,661,566 shares of this class outstanding.
The 1,655 shares to be sold were acquired on 12/20/2025 as restricted stock units from the issuer, with payment on the same date. Over the prior three months, the document lists additional common stock sales for Ryan Mac Ban, including 3,053 shares for $91,467.88 on 12/23/2025, 1,218 shares for $36,491.28 on 12/22/2025, 44,114 shares for $1,313,489.94 on 12/08/2025 noted as “10b5-1 Sales,” and 15,062 shares for $339,045.62 on 11/20/2025.
Confluent, Inc. reported that its stockholders approved the company’s planned merger with International Business Machines Corporation. At a special meeting, holders representing 247,889,521 shares formed a quorum out of 356,430,665 shares outstanding as of the January 7, 2026 record date, reflecting Confluent’s dual‑class structure with a total of 797,277,080 votes. The merger agreement received 687,954,937 votes in favor, 339,860 against and 91,336 abstentions, comfortably passing the approval threshold. Stockholders also approved, on a non‑binding advisory basis, merger‑related compensation for named executive officers with 684,382,742 votes for, 2,992,865 against and 1,010,526 abstentions. An adjournment proposal was not needed because the merger was approved. The companies expect the merger to close by the middle of 2026, subject to the remaining conditions in the merger agreement and regulatory and other customary risks highlighted in the forward‑looking statements.
Confluent, Inc. filed its annual report outlining its data streaming platform business and a pending all-cash merger with International Business Machines Corporation. Under the Merger Agreement, each Class A and Class B share will be converted into the right to receive $31.00 per share in cash, subject to customary conditions and regulatory approvals.
The company describes its role in real-time data streaming, analytics, and AI, its cloud-native product portfolio, and a global go-to-market strategy supported by major cloud and systems integration partners. Confluent also highlights key risks, including macroeconomic pressures, competitive dynamics, security and operational risks, and extensive uncertainties related to completing the IBM transaction.
Confluent, Inc. reported strong growth and improving profitability for Q4 and fiscal 2025 while progressing toward a sale to IBM. Fourth quarter 2025 total revenue rose 21% year over year to $314.8 million, with subscription revenue of $301.6 million up 20% and Confluent Cloud revenue of $169 million up 23%. Non-GAAP operating income reached $27.6 million, and non-GAAP net income per diluted share was $0.12, while GAAP net loss per share improved to $(0.23). Fiscal 2025 total revenue grew 21% to $1.1667 billion, subscription revenue was $1.1197 billion (up 21%), and non-GAAP operating income increased to $86.1 million with a 7.4% non-GAAP operating margin. Adjusted free cash flow jumped to $76.0 million from $9.5 million in 2024, and customers with at least $100,000 in ARR reached 1,521, up 10%. Confluent also highlighted its pending merger with International Business Machines Corporation, under which IBM will acquire Confluent for $31.00 per share in cash, implying an $11 billion enterprise value, with closing expected by mid-2026, subject to shareholder and regulatory approvals. Due to the proposed transaction, Confluent is not hosting an earnings call or issuing guidance.